Conference on HIV Science (IAS 2025) concluded in Kigali after five dynamic days (July 13-17), delegates left with a mix of hope and concern--buoyed by scientific breakthroughs but unsettled by a ...

The initiative will include the production of the newly approved injectable drug for HIV prevention – Lenacapavir ...

Unfortunately, the Trump administration and the Republican majorities in Congress are putting access to lifesaving ...

ViiV Healthcare has announced steps to widen access to a sought-after HIV medicine in low- and middle-income countries, ...

MELODY CHIRONDA | The Joint United Nations Programme on HIV/AIDS (UNAIDS) has warned that the global AIDS response is in ...

The World Health Organisation (WHO) released new guidelines recommending the use of injectable lenacapavir (LEN) twice a year ...

SAO PAULO, BRAZIL - A new HIV prevention drug, lenacapavir, is being called a major breakthrough. The WHO has released new ...

Thailand is examining the feasibility of adopting new global guidelines on long-acting HIV prevention, following the World Health Organisation's (WHO) launch of its latest recommendations for ...

WHO recommends twice-yearly injectable lenacapavir for HIV prevention, expanding PrEP options for key populations.